| Cell Transplantation | |
| Cell Transplantation as a Pain Therapy Targets Both Analgesia and Neural Repair | |
| Review | |
| Hongyun Huang1  Lin Chen2  Paul R. Sanberg3  Hari Shanker Sharma4  Huancong Zuo5  | |
| [1] Beijing Hongtianji Neuroscience Academy, Beijing, China;Department of Neurosurgery, Beijing Rehabilitation Hospital Affiliated Capital Medical University, Beijing, China;Beijing Hongtianji Neuroscience Academy, Beijing, China;Medical Center, Tsinghua University, Beijing, China;Department of Neurosurgery, Beijing Rehabilitation Hospital Affiliated Capital Medical University, Beijing, China;Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, FL, USA;Laboratory of Cerebrovascular Research, Department of Surgical Sciences Anaesthesiology and Intensive Care Medicine, University Hospital, Uppsala University, Sweden;Medical Center, Tsinghua University, Beijing, China; | |
| 关键词: Cell transplantation; Pain; Analgesia; Neural repair; Neurorestorative therapy; Pain neurorestoratology; | |
| DOI : 10.3727/096368913X672091 | |
| received in 2012-12-26, accepted in 2013-08-13, 发布年份 2013 | |
| 来源: Sage Journals | |
PDF
|
|
【 摘 要 】
Cell transplantation is a potentially powerful approach for the alleviation of chronic pain. The strategy of cell transplantation for the treatment of pain is focused on cell-based analgesia and neural repair. (1) Adrenal medullary chromaffin cells and the PC12 cell line have been used to treat cancer pain and neuropathic pain in both animal models and human cases. As biological or living minipumps, these cells produce and secrete pain-reducing neuroactive substances if administered directly into the spinal subarachnoid space. (2) Cell implantation for pain neurorestorative therapy is a new concept and an emerging research field for pain control along with neural repair. Possible neurorestorative mechanisms include neuroprotective, neurotrophic, neuroreparative, neuroregenerative, neuromodulation, or neuroconstructive interventions, as well as immunomodulation and enhancing the microcirculation. These factors may ultimately restore the damaged or irritated condition of the lesioned nerves. The growing preclinical and clinical data show that neural stem/progenitor cells, olfactory ensheathing cells, mesenchymal stromal cells, and CD34+ cells have the capacity to manage intractable pain and improve neurological functions. Cell delivery routes include local, intrathecal, or intravascular implants. Although these strategies are still in their infancy phase for pain neurorestoratology, cell-based therapies could open up new avenues for the relief of pain. In this review, these aspects are critically analyzed based on our own investigations. This manuscript is published as part of the International Association of Neurorestoratology (IANR) supplement issue of Cell Transplantation.
【 授权许可】
Unknown
© 2013 Cognizant Comm. Corp.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202212207817435ZK.pdf | 91KB | ||
| Table 3. | 653KB | Table |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
- [52]
- [53]
- [54]
- [55]
- [56]
- [57]
- [58]
- [59]
- [60]
- [61]
- [62]
- [63]
- [64]
- [65]
- [66]
- [67]
- [68]
- [69]
- [70]
- [71]
- [72]
- [73]
- [74]
- [75]
- [76]
- [77]
- [78]
- [79]
- [80]
PDF